Bharat Biotech, CSIR look at Bringing mRNA Vaccine Technology to India
The Council of Scientific and Industrial Research and Bharat Biotech International are looking at bringing the messenger RNA platform to India after seeing its successful use in quick development of covid-19 vaccines by US-based Pfizer and Moderna.
- CSIR-Indian Institute of Chemical Technology (CSIR-IICT) will be looking at supplying lipid nanoparticles, which are used to stabilise the drug substance for mRNA vaccines, while Bharat Biotech will manufacture the vaccine.
mRNA Vaccine
- mRNA vaccines are a new type of vaccine to protect against infectious diseases. To trigger an immune response, a mRNA vaccine teaches our cells how to make a protein or ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Kisan Kavach Suit
- 2 Hybrid Aerogel for Gold Extraction from E-Waste
- 3 New Breakthrough in Haemophilia Treatment
- 4 Cellular-Level Map of Growing Foetal Brains
- 5 India’s Zorawar Light Tank Hits Major Milestone
- 6 CE20 Cryogenic Engine: ISRO Achieves Major Milestone
- 7 Japan-India Collaboration on Space Debris Removal
- 8 IIT Bombay Unveils AroTrack
- 9 ‘One Day One Genome’ Initiative Unveiled
- 10 New Technology Enhances HIV Genome Detection
